Advancing and Characterizing Next-Gen Antibody Conjugates: Insights from BBB-Targeting Antibody Platforms
Discover next-generation antibody therapeutics, BBB-targeting platforms, and LC-QTOF workflows for advanced characterization of complex antibody-drug and oligonucleotide conjugates.